The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
Open accessAbstract
The tumor microenvironment plays a critical role in cancer progression, but the precise mechanisms by which stromal cells influence the epithelium are poorly understood. Here we show that p62 levels were reduced in the stroma of several tumors and that its loss in the tumor microenvironment or stromal fibroblasts resulted in increased tumorigenesis of epithelial prostate cancer cells. The mechanism involves the regulation of cellular redox through an mTORC1/c-Myc pathway of stromal glucose and amino acid metabolism, resulting in increased stromal IL-6 production, which is required for tumor promotion in the epithelial compartment. Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metabolism in the tumor stroma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, metabolic dysregulation of CAFs may also be coupled to altered immunoregulation, possibly through IL-6 production or depletion of immunomodulating amino acids128,132.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [128]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,727
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 306
Targeting Autophagy to Treat Cancer: Challenges and Opportunities
Lim, J., & Murthy, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.590344 · Cited by 61
The tumor microenvironment is an ecosystem sustained by metabolic interactions
Kay, E. J., & Zanivan, S. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115432 · Cited by 63
The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma
Zhang, B., Song, B., Wang, X., Chang, X., Pang, T., Zhang, X., Yin, K., & Fang, G. (2015) · Tumor Biology · doi:10.1007/s13277-015-3212-x · Cited by 59
Jiang, J., Ye, F., Yang, X. F., Zong, C., Gao, L., Yang, Y., Zhao, Q., Han, Z., & Wei, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.006 · Cited by 61
Mezawa, Y., & Orimo, A. (2021) · FEBS Journal · doi:10.1111/febs.15851 · Cited by 59
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)
Tang, J., Li, Y., Xia, S., Li, J., Yang, Q., Ding, K., & Zhang, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5257 · Cited by 57
Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression
Weber, G. F. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00257 · Cited by 56
Chen, Y., Li, Q., Li, Q., Xing, S., Liu, Y., Liu, Y., Chen, Y., Liu, W., Feng, F., & Sun, H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02038 · Cited by 56
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy
De, P. K., Aske, J. C., & Dey, N. (2021) · Cancers · doi:10.3390/cancers13205246 · Cited by 54
Zhu, G., Cao, B., Liang, X., Li, L., Hao, Y., Meng, W., He, C., Wang, L., & Li, L. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.006 · Cited by 50
Oxidative stress and prostatic diseases
Roumeguère, T., Sfeir, J., Rassy, E., Albisinni, S., Antwerpen, P. V., Boudjeltia, K. Z., Farès, N., Kattan, J. G., & Aoun, F. Y. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1413 · Cited by 50
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 50
Role of p62 in the regulation of cell death induction
Fan, L., Yin, S., Zhang, E., & Hu, H. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1445-z · Cited by 52
Semlali, A., Beji, S., Ajala, I., & Rouabhia, M. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105200 · Cited by 47
Li, J., Pu, T., Yin, L., Li, Q., Liao, C., & Wu, B. J. (2020) · Oncogene · doi:10.1038/s41388-020-1217-4 · Cited by 48
p62: Friend or Foe? Evidences for OncoJanus and NeuroJanus Roles
Emanuele, S., Lauricella, M., D’Anneo, A., Carlisi, D., Blasio, A. D., Liberto, D. D., & Giuliano, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145029 · Cited by 48
Liu, C., Billet, S., Choudhury, D., Cheng, R., Haldar, S., Fernandez, A., Biondi, S., Liu, Z., Zhou, H., & Bhowmick, N. A. (2020) · Neoplasia · doi:10.1016/j.neo.2020.11.012 · Cited by 51
Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 48
Burdelski, C. M., Reiswich, V., Hube‐Magg, C., Kluth, M., Minner, S. J. P., Koop, C., Graefen, M., Hans Heinzer, A., Tsourlakis, M. C., Wittmer, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0620 · Cited by 47
Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
Mishra, R., Haldar, S., Suchanti, S., & Bhowmick, N. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0347 · Cited by 47
miR-372inhibits p62 in head and neck squamous cell carcinomain vitroandin vivo
Yeh, L.-Y., Liu, C., Wong, Y., Chang, C., Lin, S., & Chang, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3340 · Cited by 46
Metabolic reprogramming of the tumor microenvironment by p62 and its partners
Reina‐Campos, M., Shelton, P. M., Díaz-Meco, M. T., & Moscat, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.010 · Cited by 46
Self-citationMolecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer
Lee, X. C., Werner, E., & Falasca, M. (2021) · Cancers · doi:10.3390/cancers13061211 · Cited by 48
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 46
p62 acts as an oncogene and is targeted by miR-124-3p in glioma
Deng, D., Luo, K., Liu, H., Nie, X., Xue, L., Wang, R., Xu, Y., Cui, J., Shao, N., & Zhi, F. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1004-x · Cited by 45
Regulated proteolysis of p62/SQSTM1 enables differential control of autophagy and nutrient sensing
Sanchez‐Garrido, J., Sancho‐Shimizu, V., & Shenoy, A. R. (2018) · Science Signaling · doi:10.1126/scisignal.aat6903 · Cited by 41
Yang, Z., Xu, S., Jin, P., Yang, X., Li, X., Wan, D., Zhang, T., Long, S., Xiao, W., Chen, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8726 · Cited by 42
Extracellular Citrate Fuels Cancer Cell Metabolism and Growth
Haferkamp, S., Drexler, K., Federlin, M., Schlitt, H. J., Berneburg, M., Adamski, J., Gaumann, A. K. A., Geissler, E. K., Ganapathy, V., Parkinson, E. K., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602476 · Cited by 44
Lee, M., Nam, H. Y., Kang, H., Lee, W. H., Lee, G., Sung, G., Han, M. W., Cho, K., Chang, E., Choi, K., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03539-5 · Cited by 41
Wang, Y., Lombardo, E., Avanzo, M., Zschaeck, S., Weingärtner, J., Holzgreve, A., Albert, N. L., Marschner, S. N., Fanetti, G., Franchin, G., et al. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.106948 · Cited by 41
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
Calvo‐Garrido, J., Maffezzini, C., Rosenberger, F. A., Clemente, P., Uhlin, E., Kele, M., Stranneheim, H., Lesko, N., Bruhn, H., Svenningsson, P., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.023 · Cited by 44
Xie, L., Hu, W., Hu, D., Shi, G., Li, Y., Yang, J. Y., & Prins, G. S. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6471 · Cited by 39
Sung, J., & Cheong, J. (2022) · Cells · doi:10.3390/cells11050768 · Cited by 40
Mir, S. U. R., Ormsbee, B. D., Griess, B., Vengoji, R., Tom, E. C., Kosmacek, E. A., Oberley‐Deegan, R. E., Talmon, G. A., Band, V., & Teoh-Fitzgerald, M. L. T. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01548-6 · Cited by 44
Naito, Y., Yoshioka, Y., & Ochiya, T. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02784-8 · Cited by 40
Bianchi-Frias, D., Basom, R., Delrow, J. J., Coleman, I. M., Dakhova, O., Qu, X., Fang, M., Franco, O. E., Ericson, N. G., Bielas, J. H., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0330 · Cited by 38
Inflammation research sails through the sea of immunology to reach immunometabolism
Kumar, V. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.002 · Cited by 41
Runx3 in Immunity, Inflammation and Cancer
Lotem, J., Levanon, D., Negreanu, V., Bauer, O., Hantisteanu, S., Dicken, J., & Groner, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_23 · Cited by 38
Lopes‐Coelho, F., Gouveia-Fernandes, S., & Serpa, J. (2018) · Tumor Biology · doi:10.1177/1010428318756203 · Cited by 39
Fabian, A., Stegner, S. H., Miarka, L., Zimmermann, J., Lenk, L., Rahn, S., Buttlar, J., Viol, F., Knaack, H., Esser, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.039 · Cited by 37
B-1b Cells Possess Unique bHLH-Driven P62-Dependent Self-Renewal and Atheroprotection
Pattarabanjird, T., Marshall, M., Upadhye, A., Srikakulapu, P., Garmey, J. C., Haider, A., Taylor, A. M., Lutgens, E., & McNamara, C. A. (2022) · Circulation Research · doi:10.1161/circresaha.121.320436 · Cited by 37
Janciauskiene, S. M., Wrenger, S., Günzel, S., Gründing, A. R., Golpon, H. A., & Welte, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.622076 · Cited by 35
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent
Sabbieti, M. G., Agas, D., Capitani, M., Marchetti, L., Concetti, A., Vullo, C., Catone, G., Gabai, V. L., Shifrin, V. I., Sherman, M. Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2884 · Cited by 36
Nanotechnology‐mediated photodynamic therapy: Focus on overcoming tumor hypoxia
Moloudi, K., Abrahamse, H., & George, B. P. A. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1937 · Cited by 34
Distinct mesenchymal cell states mediate prostate cancer progression
Pakula, H., Omar, M., Carelli, R., Pederzoli, F., Fanelli, G. N., Pannellini, T., Socciarelli, F., Emmenis, L. V., Rodrigues, S. D., Ribeiro, C. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44210-1 · Cited by 38
Reboredo‐Rodríguez, P., González‐Barreiro, C., Cancho-Grande, B., Simal‐Gándara, J., Giampieri, F., Forbes-Hernández, T. Y., Gasparrini, M., Afrin, S., Cianciosi, D., Manna, P. P., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.03.045 · Cited by 34
Fan, S., Wang, Y., Wu, Z., Zhang, Z.-F., Lu, J. L., Li, M., Shan, Q., Wu, D., Sun, C., Hu, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4074 · Cited by 33
P62: An emerging oncotarget for osteolytic metastasis
Zhang, J., Yang, Z., & Dong, J. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.01.003 · Cited by 34
Su, H., Waldron, R. T., Gong, R., Ramanujan, V. K., Pandol, S. J., & Lugea, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148999 · Cited by 33
Wu, J., Li, L., Wang, S., Pang, X., Wu, J., Sheng, S., Tang, Y., Tang, Y., Zheng, M. H., & Liang, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6747 · Cited by 33
Jia, H., Wei, J., Zheng, W., & Li, Z. Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06595-z · Cited by 33
Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation
Park, J. S., Kang, D. H., Lee, D. H., & Bae, S. H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.056 · Cited by 33
Therapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 32
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 33
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Tănase, C., Gheorghișan-Gălățeanu, A.-A., Popescu, I. D., Mihai, S., Codrici, E., Albulescu, R., & Hinescu, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165656 · Cited by 32
The metabolic importance of the glutaminase II pathway in normal and cancerous cells
Dorai, T., Pinto, J. T., Denton, T. T., Krasnikov, B. F., & Cooper, A. J. L. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114083 · Cited by 35
Chetta, P., & Zadra, G. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.54 · Cited by 32
Bastian, A., Thorpe, J. E., Disch, B. C., Bailey‐Downs, L. C., Gangjee, A., Devambatla, R. K. V., Henthorn, J., Humphries, K. M., Vadvalkar, S. S., & Ihnat, M. A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220335 · Cited by 31
Liang, X., Wang, C., Sun, Y., Song, W., Lin, J., Li, J., & Guan, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.134 · Cited by 31
Gruffaz, M., Yuan, H., Meng, W., Liu, H., Bae, S., Kim, J., Lu, C., Huang, Y., & Gao, S. (2019) · mBio · doi:10.1128/mbio.00866-19 · Cited by 31
Self-citationmicroRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma
Dambal, S., Giangreco, A. A., Acosta, A. M., Fairchild, A. T., Richards, Z. A., Deaton, R. J., Wagner, D., Vieth, R., Gann, P. H., Kajdacsy‐Balla, A., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.004 · Cited by 31
Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma
Denk, H., Stumptner, C., Abuja, P. M., & Zatloukal, K. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1601703 · Cited by 32
Yang, L., Ying, S., Hu, S., Zhao, X., Li, M., Chen, M., Zhu, Y., Song, P., Zhu, L., Jiang, T., et al. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0059-4 · Cited by 30
Inflammation and skeletal metastasis
Roca, H., & McCauley, L. K. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.75 · Cited by 29
Carpintero-Fernández, P., Borghesan, M., Eleftheriadou, O., Pan‐Castillo, B., Fafián‐Labora, J., Mitchell, T. P., Yuste, A., Öğrünç, M., Nightingale, T. D., Mayán, M. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04569-3 · Cited by 30
Autophagy Controls CSL/RBPJκ Stability through a p62/SQSTM1-Dependent Mechanism
Goruppi, S., Jo, S., László, C., Clocchiatti, A., Neel, V., & Dotto, G. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.043 · Cited by 29
Chen, L., Wang, Y.-Y., Deng, L., Wang, C., Wang, S.-Y., Shao, S., Zhu, Z., Zhao, J., Zhang, Y., Ruan, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.017 · Cited by 28
Regulation of glucose metabolism by p62/SQSTM1 through HIF1α
Chen, K., Zeng, J., Xiao, H., Huang, C., Hu, J., Yao, W., Gan, Y., Xiao, W., Xu, H., & Ye, Z. (2016) · Journal of Cell Science · doi:10.1242/jcs.178756 · Cited by 30
Inokuchi, S., Yoshizumi, T., Toshima, T., Itoh, S., Yugawa, K., Harada, N., Mori, H., Fukuhara, T., Matsuura, Y., & Mori, M. (2021) · Cancer Medicine · doi:10.1002/cam4.3519 · Cited by 28
The emerging era of lactate: A rising star in cellular signaling and its regulatory mechanisms
Wu, D., Zhang, K., Khan, F. A., Wu, Q., Pandupuspitasari, N. S., Tang, Y. Y., Guan, K., Sun, F., & Huang, C. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30458 · Cited by 28
Mehta, A. K., Hua, K. L., Whipple, W. J., Nguyen, M.-T., Liu, C., Haybaeck, J., Weidhaas, J. B., Settleman, J., & Singh, A. (2017) · Science Signaling · doi:10.1126/scisignal.aam6291 · Cited by 28
Wang, H., Li, Y., Shi, G., Wang, Y., Lin, Y., Wang, Q., Zhang, Y., Yang, Q., Dai, L., Cheng, L., et al. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.12.004 · Cited by 26
Han, X., & Liu, Z. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11698 · Cited by 26
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Kanwore, K., Kanwore, K., Adzika, G. K., Abiola, A. A., Guo, X., Kambey, P. A., Xia, Y., & Gao, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831636 · Cited by 26
The emerging potential role of p62 in cancer treatment by regulating metabolism
Zhang, X., Dai, M., Li, S., Li, M., Cheng, B., Ma, T., & Zhou, Z. G. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.05.004 · Cited by 30
Terasaki, M., MASAKA, S., FUKADA, C., HOUZAKI, M., Endo, T., Tanaka, T., Maeda, H., Miyashita, K., & Mutoh, M. (2019) · In Vivo · doi:10.21873/invivo.11483 · Cited by 24
Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC)
Wang, Y., Su, G., Huang, Z.-X., Wang, Z., Zhou, P., Fan, J., & Wang, Y. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737013 · Cited by 24
The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer
Zhu, W., Lü, M., Wang, X., Xu, Z., Gao, C., & Qin, L. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.016 · Cited by 25
Qi, J., He, J., Liu, C.-B., Jin, S.-M., Yang, X., Bai, H., & Ma, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.03.008 · Cited by 26
Ambrosini, G., Cordani, M., Zarrabi, A., Alcón-Rodríguez, S., Sainz, R. M., Velasco, G., González‐Menéndez, P., & Dando, I. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01462-0 · Cited by 25
Loss of p62 impairs bone turnover and inhibits PTH‐induced osteogenesis
Agas, D., Amaroli, A., Lacava, G., Yanagawa, T., & Sabbieti, M. G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29654 · Cited by 23
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component
Pakula, H., Pederzoli, F., Fanelli, G. N., Nuzzo, P. V., Rodrigues, S. D., & Loda, M. F. (2024) · Cancers · doi:10.3390/cancers16213685 · Cited by 23
Yu, J., Zhou, D., Cui, B., Zhang, C., Tan, F., Chang, S., Li, K., Lv, X., Zhang, X., Shang, S., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.004 · Cited by 23
Cirone, M., & D’Orazi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010595 · Cited by 22
Glutamine Metabolism and Prostate Cancer
Erb, H. H. H., Polishchuk, N., Stasyk, O. V., Kahya, U., Weigel, M. M., & Dubrovska, A. (2024) · Cancers · doi:10.3390/cancers16162871 · Cited by 23
Metabolic Asymmetry in Cancer: A “Balancing Act” that Promotes Tumor Growth
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.021 · Cited by 21
Tan, R.-H., Wang, F., Fan, C., Zhang, X., Zhao, J., Zhang, J., Yang, Y., Yang, X., Zou, Z., & Bu, S. (2018) · Food & Function · doi:10.1039/c8fo01617h · Cited by 23
p62 functions as a signal hub in metal carcinogenesis
Zhang, Z., & Costa, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.014 · Cited by 21
NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ
Huang, J., Linares, J. F., Durán, Á., Xia, W., Saltiel, A. R., Müller, T. D., Díaz-Meco, M. T., & Moscat, J. (2021) · Nature Communications · doi:10.1038/s41467-021-23085-0 · Cited by 20
Self-citationAl-Nakouzi, N., Wang, C. K., Oo, H. Z., Nelepcu, I., Lallous, N., Spliid, C. B., Khazamipour, N., Lo, J., Truong, S., Collins, C. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32530-7 · Cited by 19
Biase, A. D., Ma, B., Guo, J., van Dijk, L. V., Langendijk, J. A., Both, S., van Ooijen, P. M. A., & Sijtsema, N. M. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107939 · Cited by 20
Shao, C., Tu, C., Cheng, X., Xu, Z., Wang, X., Shen, J., Chai, K., & Chen, W. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.27825 · Cited by 20
Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells
Hou, H., Pan, H., Liao, W., Lee, C., & Yu, C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33127 · Cited by 20
Ogawa, K., Noda, A., Ueda, J., Ogata, T., Matsuyama, R., Nishizawa, Y., Qiao, S., Iwata, S., Ito, M., Fujihara, Y., et al. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00232-x · Cited by 20
Su, S., Cao, J., Meng, X., Liu, R., Ark, A. V., Woodford, E., Zhang, R., Stiver, I., Zhang, X., Madaj, Z., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.042 · Cited by 19
Montani, M. S. G., Tarquini, G. D., Santarelli, R., Gonnella, R., Romeo, M. A., Benedetti, R., Arena, A., Faggioni, A., & Cirone, M. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab116 · Cited by 19
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Zarrella, S., Miranda, M. R., Covelli, V., Restivo, I., Novi, S., Pepe, G., Tesoriere, L., Rodriquez, M., Bertamino, A., Campiglia, P., et al. (2025) · Metabolites · doi:10.3390/metabo15040221 · Cited by 21
Autophagy in Viral Development and Progression of Cancer
Suares, A., Medina, M. V., & Coso, O. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.603224 · Cited by 19
Metadata
- Authors
- Valencia, T., Kim, J. Y., Abu-Baker, S., Moscat-Pardos, J., Ahn, C. S., Reina-Campos, M., Duran, A., Castilla, E. A., Metallo, C. M., Diaz-Meco, M. T., & Moscat, J.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- University of Cincinnati (US)
- Corresponding author
- Moscat, Jorge
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 26
- Issue
- 1
- Pages
- 121-135
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4101061
- OpenAlex
- W2113240092
- Cited by
- 304
- References
- 62
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 13 · 2023: 12 · 2022: 29 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 28 · 2017: 27 · 2016: 31 · 2015: 23 · 2014: 6
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (R01CA132847, R01CA172025, R01CA134530, P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- p62, mTORC1, stromal fibroblasts, tumor microenvironment, metabolic reprogramming, prostate cancer, c-Myc, interleukin-6, inflammation, carcinogenesis, redox regulation, glucose metabolism, amino acid metabolism, tumor stroma
- MeSH terms
- Sequestosome-1 Protein, Mechanistic Target of Rapamycin Complex 1, Amino Acids, Animals, Cell Communication, Cell Transformation, Neoplastic, Energy Metabolism, Fibroblasts, Glucose, Heat-Shock Proteins, Humans, Inflammation, Male, Mice, Inbred C57BL, Neoplasm Invasiveness, Prostatic Hyperplasia, Prostatic Neoplasms, Time Factors, Transfection, Signal Transduction, Interleukin-6, Proto-Oncogene Proteins c-myc, Stromal Cells, Mice, Knockout, Oxidative Stress, Inflammation Mediators, Coculture Techniques, Prostatic Intraepithelial Neoplasia, RNA Interference, Cell Line, Tumor, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, PTEN Phosphohydrolase, Mice, HEK293 Cells, TOR Serine-Threonine Kinases, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review